Physiological tissue-on-a-chip technology is enabled by adapting microfluidics to create micro scale drug screening platforms that replicate the complex drug transport and reaction processes in the human liver. The ability to incorporate three-dimensional (3d) tissue models using layered fabrication approaches into devices that can be perfused with drugs offer an optimal analog of the in vivo scenario. The dynamic nature of such in vitro metabolism models demands reliable numerical tools to determine the optimum tissue fabrication process, flow, material, and geometric parameters for the most effective metabolic conversion of the perfused drug into the liver microenvironment. Thus, in this modeling-based study, the authors focus on modeling of in vitro 3d microfluidic microanalytical microorgan devices (3MD), where the human liver analog is replicated by 3d cell encapsulated alginate hydrogel based tissue-engineered constructs. These biopolymer constructs are hosted in the chamber of the 3MD device serving as walls of the microfluidic array of channels through which a fluorescent drug substrate is perfused into the microfluidic printed channel walls at a specified volumetric flow rate assuring Stokes flow conditions (Re<<1). Due to the porous nature of the hydrogel walls, a metabolized drug product is collected as an effluent stream at the outlet port. A rigorous modeling approached aimed to capture both the macro and micro scale transport phenomena is presented. Initially, the Stokes Flow Equations (free flow regime) are solved in combination with the Brinkman Equations (porous flow regime) for the laminar velocity profile and wall shear stresses in the whole shear mediated flow regime. These equations are then coupled with the Convection-Diffusion Equation to yield the drug concentration profile by incorporating a reaction term described by the Michael-Menten Kinetics model. This effectively yields a convection-diffusion–cell kinetics model (steady state and transient), where for the prescribed process and material parameters, the drug concentration profile throughout the flow channels can be predicted. A key consideration that is addressed in this paper is the effect of cell mechanotransduction, where shear stresses imposed on the encapsulated cells alter the functional ability of the liver cell enzymes to metabolize the drug. Different cases are presented, where cells are incorporated into the geometric model either as voids that experience wall shear stress (WSS) around their membrane boundaries or as solid materials, with linear elastic properties. As a last step, transient simulations are implemented showing that there exists a tradeoff with respect the drug metabolized effluent product between the shear stresses required and the residence time needed for drug diffusion.
Skip Nav Destination
ASME 2014 International Mechanical Engineering Congress and Exposition
November 14–20, 2014
Montreal, Quebec, Canada
Conference Sponsors:
- ASME
ISBN:
978-0-7918-4646-9
PROCEEDINGS PAPER
Computational Modeling of 3D Printed Tissue-on-a-Chip Microfluidic Devices as Drug Screening Platforms
Filippos Tourlomousis,
Filippos Tourlomousis
Stevens Institute of Technology, Hoboken, NJ
Search for other works by this author on:
Robert C. Chang
Robert C. Chang
Stevens Institute of Technology, Hoboken, NJ
Search for other works by this author on:
Filippos Tourlomousis
Stevens Institute of Technology, Hoboken, NJ
Robert C. Chang
Stevens Institute of Technology, Hoboken, NJ
Paper No:
IMECE2014-38454, V003T03A038; 9 pages
Published Online:
March 13, 2015
Citation
Tourlomousis, F, & Chang, RC. "Computational Modeling of 3D Printed Tissue-on-a-Chip Microfluidic Devices as Drug Screening Platforms." Proceedings of the ASME 2014 International Mechanical Engineering Congress and Exposition. Volume 3: Biomedical and Biotechnology Engineering. Montreal, Quebec, Canada. November 14–20, 2014. V003T03A038. ASME. https://doi.org/10.1115/IMECE2014-38454
Download citation file:
23
Views
Related Proceedings Papers
Related Articles
Organ-on-Chip Devices Toward Applications in Drug Development and Screening
J. Med. Devices (December,2018)
Stimuli-Responsive Triblock Polymers for Multipulse Drug Delivery
J. Med. Devices (June,2009)
Pre-Clinical Evaluation of Direct Current Ablation for the Treatment of Benign Prostatic Hyperplasia
J. Med. Devices (June,2009)
Related Chapters
Conclusions
Chitosan and Its Derivatives as Promising Drug Delivery Carriers
Industrially-Relevant Multiscale Modeling of Hydrogen Assisted Degradation
International Hydrogen Conference (IHC 2012): Hydrogen-Materials Interactions
Applications of Macro-, Micro- and Nano-Biomaterials Prepared using Biopolymers
Biopolymers Based Micro- and Nano-Materials